| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 611.5 | 426.3 | 691.1 |
| Other income | 5.3 | 4.7 | 3.7 |
| Total income | 616.9 | 431.0 | 694.8 |
| Profit before exceptional items & tax | 58.8 | 16.1 | 77.5 |
| Profit before tax | 58.8 | 16.1 | 77.5 |
| Net profit | 43.9 | 11.7 | 58.1 |
| Operating margin | 9.5% | 3.7% | 11.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -24.40% |
|---|---|
| Net profit, quarter on quarter | +275.20% |
| Revenue, year on year | -11.50% |
| Operating profit, year on year | -27.50% |
| Operating profit, quarter on quarter | +369.30% |
NSE results filing, NSE: INSECTICID. Figures extracted from the filing.
Insecticides (India) Ltd: key numbers
- Share price
- ₹602.50
- Market cap
- ₹1,753 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 14.0×Sector 37.5×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Earnings Call Transcript: Key Takeaways
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
- Call
- Guides 100% growth
Insecticides (India) Investor Presentation: Key Takeaways
IIL reported FY26 turnover of ₹2,140 Cr, focusing on premiumization via its 'Tractor Brand'. Strategy emphasizes innovative product launches and international collaborations to shift towards high-margin B2C segments.
Insecticides (India) Earnings Call: Key Takeaways
IIL delivered FY26 revenue of ₹2,140cr (up 7%) with EBITDA of ₹227cr. Strategy focuses on premiumization via the Kaeros brand and R&D partnerships with Nissan and Corteva.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides India delivered steady 7% revenue growth in FY26, balancing raw material inflation through premiumization and strategic partnerships while preparing for a major brand expansion via its new subsidiary, Kairos.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides (India) reported FY26 turnover of ₹2,140 Cr. Company shifting toward premiumization with B2C premium product share rising from 51% (FY23) to 58% (FY26).